All News

Two studies published in The Lancet have developed models to examine what may happen if the World Health Organization commits to a 3-part strategy to end cervical cancer.

Clinical trials are now evaluating the potential combination of PARP inhibitors with immunotherapy or other agents in patients with ovarian cancer.

Meaningful improvements in outcomes with immunotherapy in recent years are finally starting to change the tide for the first-line treatment of patients with small-cell lung cancer.

Study suggests that the ACA improved financial risk protection against medical bills for low-income adults.

Current recommendation of beta blockers in patient with HF include bisoprolol, carvediol, or metoprolol succinate. Metoprolol tartrate may provide better rate control with twice daily dosing.

An awards ceremony at the Pharmapack Europe exhibition and conference in Paris recognized pioneering packaging innovations that have significantly contributed to improving user safety, ease of use, and other health care needs.

Merck has announced its plan to spin-off products from its women's health, trusted legacy brands, and biosimilars into a new, independent, and publicly traded corporation, according to the company.

There is still no vaccine or effective antiviral treatment for the novel coronavirus (2019-nCoV) that continues to spread worldwide, and health care providers should be aware of the symptoms.

To streamline the way opioid treatments are administered and to successfully treat addicts, a pharmacist’s clinical expertise is maximized in a medication-assisted treatment setting within opioid treatment programs.

Is changing the prednisolone taper to a prednisone taper a good option due to the drug shortage?

Each year, infections related to antibiotic-resistant superbugs kill 700,000 people worldwide, according to researchers at the Italian Society of Anti-Infective Therapy (SITA).

Published in the Journal of the American Medical Association, the study was conducted using a segmented regression analysis of an interrupted time series over a course of 30 months.

Audible prescription labels will be available in-store at more than 420 Canadian pharmacy locations, including those at Lawtons Drugs, Sobeys, Safeway, Thrifty Foods, Foodland, IGA (western Canada), and FreshCo.

CourMed delivers a multitude of health care items, such as prescription meds, vitamins, supplements, and other health care items through a crowdsourced network of delivery drivers.

Treatment with niraparib resulted in a 38% reduction in the risk of disease progression or death in the overall study population compared with placebo.

Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year.

Top news from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

The Pharmacist Moms Group has established a database for pharmacists that gives them access and visibility to help broaden their career opportunities.

Vizient is taking a strategic approach to lowering drug costs and shortages with the recent creation of an Essential Medicines list.

With emerging research from The Sidney Kimmel Cancer Center-Jefferson Health, outcomes in patients with uveal melanoma that has metastasized were shown to significantly improve with changes in treatment.

Which crime novelist incorporated her knowledge of pharmacy into her books?

Both semaglutide and dulaglutide are dosed once weekly for treatment of type 2 diabetes.

In addition to safety and tolerability, a pair of clinical studies will evaluate the drug’s efficacy and ability to slow disease progression and to improve quality of life in patients with amyotrophic lateral sclerosis.

A study conducted by LSU Health found that by the time recommended screening for colorectal cancer begins, the disease has already spread in a high percentage of patients.

The survey, administered by the National Community Pharmacists Association (NCPA), aimed to evaluate how pharmacists and their patients are handling concerns about 2019-nCoV.

Top news from across the health care landscape.

These changes would lower the beneficiary cost sharing on more expensive prescription drugs, promote the use of generic medications, and allow beneficiaries to know in advance and compare their out-of-pocket payments for different prescription drugs.